Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Leukemia|April 15, 2018
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemiaMelissa A Burns, Zi Wei Liao, Natsuko Yamagata, et al.
The Journal of Molecular Diagnostics : JMD|July 7, 2023
Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid TumorsHarrison K Tsai, Tasos Gogakos, Va Lip, et al.
Plos One|November 14, 2019
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemiaGayle P Pouliot, James Degar, Laura Hinze, et al.
Metabolomics : Official Journal of the Metabolomic Society|June 27, 2021
Impact of acute lymphoblastic leukemia induction therapy: findings from metabolomics on non-fasted plasma samples from a biorepositoryToshie Saito, Yue Wei, Li Wen, et al.
Blood|June 22, 2016
Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutationsAbner Louissaint, Kristian T Schafernak, Julia T Geyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2017
Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategyAlanna J Church, Monica L Calicchio, Valentina Nardi, et al.
Nature Communications|November 21, 2025
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemiaCaroline R M Wiggers, Eugene Y Cho, Merve Ozdemir, et al.
Blood Advances|May 5, 2026
Combining Menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemiaNastassja Keora Scheidegger, Constanze Schneider, Gabriela Alexe, et al.
Blood Advances|March 7, 2018
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemiaThai Hoa Tran, Marian H Harris, Jonathan V Nguyen, et al.
Blood Advances|June 27, 2018
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001Lynda M Vrooman, Traci M Blonquist, Marian H Harris, et al.
Pageof 7